SMTI | tickerfilter.com

Fundamental analysis

12%

Profitability 0%

Dept financing 22%

Liquidity 22%

Performance 20%

Company vs Stock growth

21.672 M 26.305 M

4.634 M 21.38%

34.600 31.200

-3.400 -9.83%

+ Add row to compare

Performance

5 Days

-2.77%

1 Month

-14.00%

3 Months

-16.17%

6 Months

-15.77%

1 Year

-19.13%

2 Year

-45.61%

Key data

Stock price

$27.02

P/E Ratio

0.00

DAY RANGE

$26.81 - $29.00

EPS

-$0.80

52 WEEK RANGE

$25.90 - $39.08

52 WEEK CHANGE

-$18.15

MARKET CAP

290.207 M

YIELD

N/A

SHARES OUTSTANDING

8.747 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

05-12-2025

BETA

1.19

PUBLIC FLOAT

AVERAGE 10 VOLUME

$45,838

AVERAGE 30 VOLUME

$30,319

Company detail

CEO: Zachary B. Fleming
Region: US
Website: sanaramedtech.com
Employees: 60
IPO year: 2007

Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Sanara MedTech Inc. develops, markets, and distributes wound and skin care products. It offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties. The company also provides HYCOL Hydrolyzed Collagen Powder and Gel for the management of full and partial thickness wounds.

SMTI - Sanara MedTech Inc.